Ciprofloxacin safety to pediatric patients

The Use of Systemic Fluoroquinolones FROM THE. - Pediatrics

Disclaimer: Please note that abstracts for content published before 1996 were created through dital scanning and may therefore not exactly replicate the text of the orinal print issues.

Fluoroquinolone Use in Paediatrics Focus on Safety and Place in.

All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies.

The Use of Systemic Fluoroquinolones FROM THE. - <b>Pediatrics</b>

Cipro Ciprofloxacin Drug Information Clinical Pharmacology -.

A multicenter, observational, comparative cohort study was conducted between 19 in French pediatric departments.

Cipro/ Ciproxin 0.3% w/v Ciprofloxacin - Generic

The only indications for which a fluoroquinolone (ie, ciprofloxacin) is licensed by the US Food and Drug Administration for use in patients younger than 18 years are complicated urinary tract infections, pyelonephritis, and postexposure treatment for inhalation anthrax.Ciprofloxacin Extended-Release Tablets


Ciprofloxacin safety to pediatric patients:

Rating: 87 / 100

Overall: 91 Rates